POPULATION OF CD3-NEGATIVE CELLS THAT EXPRESS CHEMOKINE RECEPTOR AND CELL ADHESION MOLECULE, USE OF THE SAME, AND METHOD FOR PRODUCING THE SAME
The present invention relates to an immunocyte having higher cytotoxic activity, and a pharmaceutical composition for NK cell therapies, for which high effect can be expected. The present invention provides a cell population including CCR5-positive, CCR6-positive, CXCR3-positive, and CD3-negative ce...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
01.04.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to an immunocyte having higher cytotoxic activity, and a pharmaceutical composition for NK cell therapies, for which high effect can be expected. The present invention provides a cell population including CCR5-positive, CCR6-positive, CXCR3-positive, and CD3-negative cells. The present invention provides the cell population, wherein the CCR5-positive, CCR6-positive, CXCR3-positive, and CD3-negative cells further highly express CD11c. The present invention provides a CCR5-positive, CCR6-positive, CXCR3-positive, and CD3-negative cell, which infiltrates into a solid tumor. The present invention also provides a pharmaceutical composition containing such a cell population and a pharmaceutically acceptable additive. The present invention further provides a method for producing the aforementioned cell population. |
---|---|
AbstractList | The present invention relates to an immunocyte having higher cytotoxic activity, and a pharmaceutical composition for NK cell therapies, for which high effect can be expected. The present invention provides a cell population including CCR5-positive, CCR6-positive, CXCR3-positive, and CD3-negative cells. The present invention provides the cell population, wherein the CCR5-positive, CCR6-positive, CXCR3-positive, and CD3-negative cells further highly express CD11c. The present invention provides a CCR5-positive, CCR6-positive, CXCR3-positive, and CD3-negative cell, which infiltrates into a solid tumor. The present invention also provides a pharmaceutical composition containing such a cell population and a pharmaceutically acceptable additive. The present invention further provides a method for producing the aforementioned cell population. |
Author | Harada, Yui Yonemitsu, Yoshikazu |
Author_xml | – fullname: Harada, Yui – fullname: Yonemitsu, Yoshikazu |
BookMark | eNqNjLsKwjAYhTvo4O0dfnC1UFs6OIbkb1NMk5CLuJUicZK2UN_DV7YVcXY6nMN3vnW06PourKKXVtoL4iolQRVAWRZLLKd-QaAohAXHiQO8aoPWAuVYq3MlEQxS1E4ZIJJ9SCCMo509tRJIvcADeIuz1XEES-ppmOEaHVcMiumrjWKeVrL8IdtoeW8fY9h9cxPtC3SUx2HomzAO7S104dl4mybpMTnlaZ6QY_Yf9QY2jkH9 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US2021095250A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US2021095250A13 |
IEDL.DBID | EVB |
IngestDate | Fri Aug 30 05:41:40 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US2021095250A13 |
Notes | Application Number: US201917041061 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210401&DB=EPODOC&CC=US&NR=2021095250A1 |
ParticipantIDs | epo_espacenet_US2021095250A1 |
PublicationCentury | 2000 |
PublicationDate | 20210401 |
PublicationDateYYYYMMDD | 2021-04-01 |
PublicationDate_xml | – month: 04 year: 2021 text: 20210401 day: 01 |
PublicationDecade | 2020 |
PublicationYear | 2021 |
RelatedCompanies | GAIA BioMedicine Inc Yonemitsu Yoshikazu |
RelatedCompanies_xml | – name: Yonemitsu Yoshikazu – name: GAIA BioMedicine Inc |
Score | 3.330729 |
Snippet | The present invention relates to an immunocyte having higher cytotoxic activity, and a pharmaceutical composition for NK cell therapies, for which high effect... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
Title | POPULATION OF CD3-NEGATIVE CELLS THAT EXPRESS CHEMOKINE RECEPTOR AND CELL ADHESION MOLECULE, USE OF THE SAME, AND METHOD FOR PRODUCING THE SAME |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210401&DB=EPODOC&locale=&CC=US&NR=2021095250A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ1bS8MwFIDDmKK-6VS8TAkofbK4ra3bHoZ0SboqbVN6GXsb25qCIN1wFX-Gf9mT7OKe9pbL4UBOOUm-nOQUocesZczMjin0vGHkutmZZeBS3Vxv5ZOp1RBmZ5LJiK4fvLip-T6yRhX0uXkLo_KE_qjkiOBRM_D3Us3Xi_9DLKruVi6fpx_QNH91kh7V1nQM_AK8oNF-j4WccqIR0ktjLYhWfV0Zw7OBlQ7kRlpm2mfDvnyXsthdVJxTdBiCvqI8QxVR1NAx2fx7rYaO_HXIG4pr71ueo9-Qh6mnDpUwdzChhh6wAdSHDBPmeTFOXDvBbKTMimW2Aw50znDECAsTHmE7oEoS29RlchrFPvcYST32hNOYSa2Jy3Bs-9AghX2WuJxiQEUcRpym5C0YbEUu0IPDEuLqMLLx1pDjNN41g3GJqsW8EFcIt_N2ZjVFty0MwxQADS2gKAvwLGvmsKOYXKP6Pk03-7tv0Ymsru671FG1_PoWd7CUl9N79QX-ABcVlYM |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ3dT8IwEMAbgkZ8U9T4gdpEsycXgW0CD8SMtmPoti77ILwRYF1iYgaRGf8M_2Wv40OeeNt6l0t2zbX99dobQo9JU5vpbV2oaV1LVb09SyCkOqnaTCdToy709iSRGV3Xe7Fj_W1kjEroc3MXpqgT-lMUR4SImkG858V4vfjfxKLF2crl8_QDmuavVtSlypqOgV-AFxTa6zKfU04UQrpxqHjBStaROTwTWOmgJevzysXTsCfvpSx2JxXrBB36YC_LT1FJZFVUIZt_r1XRkbtOecPjOvqWZ-jX537sFJtKmFuYUE31WB_ehwwT5jghjmwzwmxUuBXLagcc6JzhgBHmRzzApkcLTWxSm8lhFLvcYSR22BOOQyatRjbDoelCg1R2WWRzigEVsR9wGpOB19-qnKMHi0XEVuHLxltHjuNw1w3aBSpn80xcItxKW4nREJ2W0DRdADQ0gaIMwLOkkcKKYnKFavssXe8X36OKHbnO2Bl47zfoWIpWZ19qqJx_fYtbmNbz6V3RG38_hZhw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=POPULATION+OF+CD3-NEGATIVE+CELLS+THAT+EXPRESS+CHEMOKINE+RECEPTOR+AND+CELL+ADHESION+MOLECULE%2C+USE+OF+THE+SAME%2C+AND+METHOD+FOR+PRODUCING+THE+SAME&rft.inventor=Harada%2C+Yui&rft.inventor=Yonemitsu%2C+Yoshikazu&rft.date=2021-04-01&rft.externalDBID=A1&rft.externalDocID=US2021095250A1 |